Abivax S.A. — Investor Relations & Filings
Abivax S.A. is a clinical-stage biotechnology company focused on developing therapeutics for chronic inflammatory diseases by harnessing the body's natural regulatory mechanisms. The company's core strategy revolves around modulating the immune response through microRNA (miRNA). Its lead drug candidate, obefazimod, is an investigational, orally administered small molecule with a novel mechanism of action. Obefazimod is designed to enhance the expression of miR-124, a key microRNA that regulates the inflammatory response. The primary development goal is the commercialization of obefazimod for the treatment of ulcerative colitis, with clinical programs also underway for Crohn's disease. The company is exploring obefazimod for other inflammatory indications and is investigating follow-on compounds from its proprietary chemical library.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-8 - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | |
| 20-F - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | |
| 6-K - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | |
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| Major Shareholding Notification 2026 | 2026-01-14 | English | |
| Regulatory Filings 2026 | 2026-01-08 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 33016665 | S-8 - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | ||
| 33016505 | 20-F - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | ||
| 33016424 | 6-K - Abivax S.A. (0001956827) (Filer) | 2026-03-23 | English | ||
| 32249312 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 13630008 | Major Shareholding Notification 2026 | 2026-01-14 | English | ||
| 13630005 | Regulatory Filings 2026 | 2026-01-08 | English | ||
|
2025
9 filings
| |||||
| 13630007 | 6-K | 2025-12-15 | English | ||
| 13630010 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13630009 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13630012 | Major Shareholding Notification 2025 | 2025-10-30 | English | ||
| 13630011 | Regulatory Filings 2025 | 2025-10-28 | English | ||
| 13630013 | 6-K | 2025-09-08 | English | ||
| 13630014 | Major Shareholding Notification 2025 | 2025-08-14 | English | ||
| 13630016 | Major Shareholding Notification 2025 | 2025-07-31 | English | ||
| 13630017 | 424B5 | 2025-07-24 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
Abivax S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30868/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30868 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30868 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30868 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30868}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Abivax S.A. (id: 30868)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.